BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7998907)

  • 1. The interaction between CD4 and MHC class II molecules and its effect on T cell function.
    Vignali DA
    Behring Inst Mitt; 1994 Jul; (94):133-47. PubMed ID: 7998907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.
    Gay D; Maddon P; Sekaly R; Talle MA; Godfrey M; Long E; Goldstein G; Chess L; Axel R; Kappler J
    Nature; 1987 Aug 13-19; 328(6131):626-9. PubMed ID: 3112582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4 and CD8 recognition of class II and class I molecules of the major histocompatibility complex.
    Fleury SG; Croteau G; Sékaly RP
    Semin Immunol; 1991 May; 3(3):177-85. PubMed ID: 1909595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of CD4 with MHC class II molecules, T cell receptors and p56lck.
    Vignali DA; Doyle C; Kinch MS; Shin J; Strominger JL
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):13-24. PubMed ID: 7506833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topology of T cell receptor-peptide/class I MHC interaction defined by charge reversal complementation and functional analysis.
    Chang HC; Smolyar A; Spoerl R; Witte T; Yao Y; Goyarts EC; Nathenson SG; Reinherz EL
    J Mol Biol; 1997 Aug; 271(2):278-93. PubMed ID: 9268659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.
    König R; Huang LY; Germain RN
    Nature; 1992 Apr; 356(6372):796-8. PubMed ID: 1574118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.
    Henderson SC; Berezovskaya A; English A; Palliser D; Rock KL; Bamezai A
    J Immunol; 1998 Jul; 161(1):175-82. PubMed ID: 9647222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modelling of co-receptor CD8 alpha alpha and its complex with MHC class I and T-cell receptor in sea bream (Sparus aurata).
    Costantini S; Buonocore F; Facchiano AM
    Fish Shellfish Immunol; 2008 Dec; 25(6):782-90. PubMed ID: 18951040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MHC class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design.
    Zeng G
    J Immunother; 2001; 24(3):195-204. PubMed ID: 11394496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation and function of mouse T-cells with a transgenic TCR positively selected by highly disparate xenogeneic porcine MHC.
    Zhao Y; Rodriguez-Barbosa JI; Zhao G; Shaffer J; Arn JS; Sykes M
    Cell Mol Biol (Noisy-le-grand); 2001 Feb; 47(1):217-28. PubMed ID: 11292257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-mediated presentation of MHC class II molecules guides thymocytes to the CD4 lineage.
    Komaniwa S; Hayashi H; Kawamoto H; Sato SB; Ikawa T; Katsura Y; Udaka K
    Eur J Immunol; 2009 Jan; 39(1):96-112. PubMed ID: 19089815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profound enhancement of T cell activation mediated by the interaction between the TCR and the D3 domain of CD4.
    Vignali DA; Vignali KM
    J Immunol; 1999 Feb; 162(3):1431-9. PubMed ID: 9973399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The orientation of a T cell receptor to its MHC class II:peptide ligands.
    Hong SC; Sant'Angelo DB; Dittel BN; Medzhitov R; Yoon ST; Waterbury PG; Janeway CA
    J Immunol; 1997 Nov; 159(9):4395-402. PubMed ID: 9379037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC and T cell development.
    Viret C; Janeway CA
    Rev Immunogenet; 1999; 1(1):91-104. PubMed ID: 11256575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cell adhesion mediated by CD8 and MHC class I molecules.
    Norment AM; Salter RD; Parham P; Engelhard VH; Littman DR
    Nature; 1988 Nov; 336(6194):79-81. PubMed ID: 3263576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in CD4-binding regions of the MHC class II molecule I-Ek do not impede CD4+ T cell development.
    Yelon D; Schaefer KL; Berg LJ
    J Immunol; 1999 Feb; 162(3):1348-58. PubMed ID: 9973389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retroviral antibody binding of the MHC class II molecule: a biochemical influence on CD4 T cell differentiation in HIV infection?
    Powell PD; Demartini JC
    J Theor Biol; 2001 Mar; 209(2):155-60. PubMed ID: 11401457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The duration of antigen receptor signalling determines CD4+ versus CD8+ T-cell lineage fate.
    Yasutomo K; Doyle C; Miele L; Fuchs C; Germain RN
    Nature; 2000 Mar; 404(6777):506-10. PubMed ID: 10761920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th cells and Th2 responses can develop in the absence of MHC class II-CD4 interactions.
    Wack A; Corbella P; Harker N; Roderick K; Norton T; Williams K; Williams O; Kioussis D
    J Immunol; 1999 Aug; 163(3):1162-9. PubMed ID: 10415010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.